Sleep disturbance is commonly reported by participants with posttraumatic stress disorder, but objective evidence of poor sleep is often absent. Here we compared self-report and actigraphic evaluations of sleep between veterans with post-traumatic stress disorder and controls. Participants reported their sleep retrospectively for the month before the recording night and on the recording night. On the recording night, they wore an Actiwatch-64 and were instructed to press the marker button upon getting into bed, each time they awoke, and at their final awakening. The post-traumatic stress disorder group reported much worse sleep than controls on the Pittsburgh Sleep Quality Index for the previous month and somewhat poorer sleep on the recording night. However, on the recording night, neither diary nor actigraphic measures of number of awakenings, total time in bed, nor time lying awake after sleep onset differed between participants with and without post-traumatic stress disorder. Diary-reported number of awakenings was fewer than actigraphically captured awakenings. These results suggest a memory bias towards remembering worse sleep on the nights before the recording night.
IN TROD UCTI ON
A hallmark symptom of post-traumatic stress disorder (PTSD) is sleep disturbance, which can persist even after successful treatment (Galovski et al., 2009) . Treating insomnia is of central importance for PTSD, with a number of treatments available (Foa et al., 2010) . Evaluating the success of these treatments presumes that sleep can be adequately assessed. The least common and most inconvenient method is polysomnography (PSG), which is almost always carried out in a sleep laboratory. It is the most detailed and accurate assessment, affording scoring of sleep stages and recording of breathing symptomatic of sleep apnea. The most common and simplest method is self-report, either in response to questions from an evaluator or on a questionnaire. Self-report can be valuable clinically but is limited by various kinds of response biases, such as the inability to correctly perceive or remember the night's sleep. Between these two methods in simplicity and convenience is actigraphic sleep measurement, where a watch-like device is worn on the wrist. However, actigraphy has a serious limitation in that it is inaccurate in recognizing whether periods of inactivity in bed are sleeping or lying quietly awake (Chae et al., 2009; Tryon, 2004; Van De Water et al., 2011) .
Research has consistently found that patients with PTSD report poor sleep on the Pittsburgh Sleep Quality Index (PSQI) and on sleep diaries. Yet, actigraphic findings often fail to corroborate these self-reports (Calhoun et al., 2007; Ghadami et al., 2015; Klein et al., 2003; Kobayashi et al., 2007 Westermeyer et al., 2007) . Some have suggested that patients with PTSD experience 'sleep state misperception', as an explanation for the failure of objective and subjective sleep measures to match (Caldwell and Redeker, 2005) . Sleep state misperception is common in patients with general insomnia, who overestimate their sleep latency and underestimate their total sleep time (TST; Harvey and Tang, 2012) .
In a previous publication (Bertram et al., 2014) , we reported on autonomic arousal during actigraphically estimated sleep in participants with and without PTSD. Neither of the two actigraphic measures, TST nor wake time percentage, showed group differences. The aim of this study was to analyse the same sample in detail for relationships between self-report and a more standardized method of actigraphy scoring than we reported previously. Self-reports included a 1-month retrospective PSQI and, for the recording night, a 1-night PSQI and a sleep diary. We hypothesized that participants with PTSD would have poorer sleep quality than age-and sex-matched participants without PTSD on both the PSQI questionnaires and the sleep diary. In addition, we wanted to test whether the participants with PTSD would have lower actigraphic sleep quality as evidenced in length of sleep (TST), sleep-onset latency (SOL), wake after sleep onset (WASO) and number of awakenings (NAW). Our analyses also examined the effects of taking sleep medication on the recording night.
MATERI ALS AND METHODS

Participants
Data were obtained at the initial assessment of a randomized clinical trial at a Veterans Affairs (VA) hospital (Bertram et al., 2014) . Sixty veterans with current PTSD (PTSD group) were compared with a demographically similar group of 43 veterans and 17 civilians who never had met criteria for PTSD (control group). Veterans often report worse sleep than non-veterans, but we did not restrict our control group to veterans so that we could analyse sleep apart from veteran status. The research was approved by the Stanford and VA Palo Alto human research committees, and written informed consent was collected from all participants.
Exclusion criteria for both groups included psychotic disorder, substance use disorder in the past 3 months, bipolar I disorder and cognitive disorder. None of the participants met current criteria for bipolar II, although this was not an exclusion criterion. We also excluded those with moderate or severe traumatic brain injury as defined by more than 7 days of post-traumatic amnesia (PTA) from selfreport, categorized using an adapted PTA scale. Those with a score from 0 to 3 on a 7-point scale were excluded (Rao and Lyketsos, 2000) .
Procedure
Participants were given the Structured Clinical Interview for DSM-IV Disorders (First et al., 2002) , and the ClinicianAdministered PTSD Scale (CAPS; Blake et al., 1995) . Symptoms on the CAPS were scored as current if they occurred at least once in the previous month with at least moderate intensity (Weathers et al., 1999) . Participants filled out self-report questionnaires asking for demographic data and psychological symptoms, including the Beck Depression Inventory-II (BDI; Beck et al., 1996) , the PSQI (Buysse et al., 1989) , the PSQI Addendum for PTSD (Germain et al., 2005) , and the Dysfunctional Beliefs and Attitudes about Sleep Scale (DBAS; Morin et al., 2007) . A 24-h monitoring questionnaire was given to participants, which included the 1-night PSQI with the PTSD Addendum and the sleep diary. The sleep diary (Appendix S1) asked participants about specific times they went to bed intending to sleep, how long it took them to fall asleep, how many times and why they woke up, and what time they woke up and got out of bed in the morning. The 1-night PSQI and PTSD Addendum had the same questions as the 1-month PSQI, but inquired only about the previous night. Participants were asked whether they ever had been diagnosed with sleep apnea and if they used a continuous positive airway pressure machine during the recording night. In addition, medical records were consulted when available.
Participants were fitted with several ambulatory monitoring devices to wear outside of the laboratory for up to 24 h, as described in Bertram et al. (2014) . For actigraphy, participants wore the Actiwatch-64 (Respironics, Bend, Oregon, USA) on their dominant wrist. They were instructed to press the marker button on the watch before going to bed and upon rising, and for any awakenings during the night. At the end of the recording period, they returned to the laboratory for removal of the devices and to return the questionnaire packets.
Analysis
Actigraphic data were recorded using 15-s epoch lengths. Up to 24 h of data were downloaded and analysed with the Actiware 6 program set at a medium wake threshold. Data were manually edited by laboratory members unaware of patient diagnosis, following explicit written rules developed in our laboratory. The rest interval or time in bed was based on marker button presses by the participant. Sleep was defined as periods of at least 15 min of low and intermittent activity, with at least 5 min of zero activity. The final awakening was defined as the last epoch with an activity level of zero, followed by at least 90 min of no sleep. If the marker buttons did not match activity at the start or end of the rest interval, the rest interval was established by reviewing the Actiwatch activity for epochs of zero activity as well as the diary selfreport of sleep and wake time. If markers matched activity, the rest interval start and end times were set as the first marker and last marker, respectively. If not, our team used rules for scoring valid start and end marker button presses to identify the rest interval, which are detailed in Appendix S2. If the start or end of sleep onset was more than 15 min before or after a marker press, we used the sleep-onset period to define the start or end of a rest interval. Sleep onset was identified as the first minute of more than 5 min of zero ª 2017 European Sleep Research Society activity level within a rest interval. Scoring of the marker presses throughout the night was done by identifying valid marker presses in between the start and end sleep markers. Participants who failed to press any marker buttons were considered non-compliant and excluded from the analysis (n = 5). The Actiware program calculated rest interval variables (start time, end time and duration) and sleep interval variables [SOL, wake time, NAW (number of marker button presses) and TST].
The actigraphy, questionnaires and demographics data were exported into SPSS v21 for statistical analysis. The alpha level was set at less than 0.05 for statistical significance. The 1-month PSQI was analysed in the usual way (Buysse et al., 1989) , but the 1-night PSQI was modified by removing habitual sleep efficiency and sleep medication use from the total score and sub-scores, as these would be inaccurately reflected in a 1-night assessment and would bias the analysis of the medication use factor. An additional analysis of variance (ANOVA) compared the 1-month with the 1-night PSQI. For this analysis, the two measures were made comparable by removing sleep medication and habitual sleep efficiency items from both PSQI versions. The following variables were calculated from the sleep diaries: TST, by subtracting SOL and duration of awakenings from time in bed; WASO, the sum of all minutes reported awake after falling asleep; SOL, by subtracting the minutes it took to fall asleep from the reported bed time; and NAW, from the reported number of awakenings on the night of monitoring. Statistical demographic differences between groups were calculated using one-way ANOVA for continuous variables, and chi-square tests for categorical variables. A two-way ANOVA examined the 1-month and 1-night PSQI between groups (PTSD and control) by sleep medication use (yes or no). Pearson correlations quantified the associations between actigraphic and diary-based sleep variables. A series of three-factor mixed ANOVAs examined the interaction of measurement method (actigraphic or diary), group (PTSD or control) and sleep medication use (yes or no). A post hoc Bonferroni correction for the repeated-measures analyses was performed for the PSQI with a corrected P > 0.001. Because of missing data, the number of participants included varied for group and sleep medication use. We conducted missing value analyses for all variables, and did not find significant patterns in the missing data. To adjust for missing (Dong and Peng, 2013) . These imputations were performed for three variables on the 1-night PSQI (latency, disturbance and daytime dysfunction) and two sleep diary variables (WASO and TST).
RESUL TS
A total of 167 persons were interviewed for the study. Of these, 33 refused to wear the devices or were ineligible. We excluded one shift worker, eight for device failures and five for non-compliance with the marker button instructions. A total of 120 met criteria for the study, 60 in each group. Thirtynine of the PTSD group and 50 of the control group did not take sleep medications on the night of monitoring. The demographics of these groups are listed in Table 1 . The mean (SD) age of the PTSD group was 53.1 (11.1) years and 54.5 (9.2) years for the control group; 49% of the PTSD group and 66% of the controls were white, and a majority of both groups had at least some college education. The PTSD group was more likely to report history of a traumatic brain injury with 30 min to 7 days of PTA, and tended to report sleep apnea more often; 25% of the PTSD group said they had a trauma nightmare on the monitored night. They also scored significantly worse on the 1-month and monitoring night PSQI and PTSD Addendum. The PTSD group scored worse than controls on questionnaires for depression (BDI), anxiety (Beck Anxiety Inventory; BAI) and DBAS.
Results of the 1-month PSQI ANOVAs scores are summarized in Table 2 . We added sleep medication use on the night of monitoring as a variable for analyses as there was a considerable amount of medication use in both groups. PTSD participants reported significantly worse sleep quality than controls on the PSQI, PSQI subscales and the PTSD Addendum. Our control group was similar to the PTSD group on poor sleep quality, with 56% scoring above 5 on the monthly PSQI. The use of sleep medication was associated with worse total PSQI scores in both groups and worse sleep latency on the PSQI subscale, especially in controls, as shown by a significant group 9 medication interaction. Effect sizes were moderate to small. Results of the ANOVAs from the 1-night PSQI are summarized in Table 3 . We omitted the subscale analyses of 'sleep medication use' and 'habitual sleep efficiency' (as well as from the total score calculation) due to the inability to interpret habitual sleep patterns with 1-night recall. PTSD and control groups scored higher on the total score on the subscales sleep disturbance and daytime dysfunction due to the prior night's sleep. For both groups, those who used sleep medication scored significantly worse on sleep latency. The PSQI PTSD Addendum was also significantly affected by sleep medication use regardless of PTSD status. Effect sizes for the daytime dysfunction subscale were moderate, but small for other significant results.
An ANOVA analysis comparing the 1-night with the 1-month PSQI for the total score and PTSD Addendum was conducted to look at potential memory bias between participants recalling sleep over 1 month as compared with the night of monitoring. For this analysis, we omitted sleep medication use and habitual sleep efficiency from the total scores in 1-month and 1-night calculations; the results are shown in Table 4 . There were significant group, measure, and group 9 measure interactions for the 1-month total score and PTSD Addendum, as well as medication effects for the 1-month PSQI.
Measures compared between actigraphy and diary on the night of monitoring were TST, SOL, WASO and NAW, measured by number of marker button presses on the actigraphy watch and reported NAW in the sleep diary. Correlations between the self-reported diary and actigraphic measures for the night of recording indicate how consistently the two kinds of measurements assessed the underlying sleep variable. Overall, TST (r = 0.49, P < 0.01), WASO (r = 0.27, P < 0.05) and NAW (r = 0.57, P < 0.01) significantly correlated between diary and actigraphy variables among the study population. These correlations were significant in PTSD participants that did and did not take sleep medications but, among control participants, only TST and NAW were correlated regardless of sleep medication use. As shown in Table 5 , repeated-measure ANOVAs of these measures showed significant main effects for SOL, WASO and NAW based on measurement method (actigraphic or diary), but not for group (PTSD or control). Measured by actigraphy, SOL was shorter and NAW more frequent compared with the diary. SOL was the only variable that showed a three-way interaction (Fig. 1) . SOL was longest based on self-report in the diary for controls who took sleeping medications.
DI SCUSSION
We tested the ability of a variety of self-report questions and actigraphic sleep measures to distinguish individuals with and without PTSD, expecting that the PTSD group would both report and demonstrate poorer sleep. Instead we found that on the monitoring night, specific sleep parameters assessed in parallel by actigraphy and self-report gave the same result of minimal group differences. For most items, reports by our PTSD group for the prior month indicated poorer sleep than reports on the monitoring night. Comparing 1-month and 1-night PSQIs confirmed that participants reported their sleep differently for the two time periods. According to actigraphic measures, diary measures overestimated SOL and underestimated NAW in both PTSD participants and controls, while there were no group or measurement method differences in TST or WASO.
Insomniacs often misreport SOL and TST compared with objective measures (Harvey and Tang, 2012) , which might be a reason for the overestimation of SOL by our participants compared with actigraphy. For both groups, an intensity bias towards recalling more severe sleep disturbance and a confirmation bias towards reporting sleep that met expectations of sleeping poorly may have contributed to self-reports. In addition, depression leads people to report and interpret events more negatively, which could have played a role in the reports of worse sleep in our more depressed PTSD group. A tendency towards remembering past nights when sleep was disturbed, especially when those nights were recent, could have affected the PTSD group more. Yet the two groups were equally biased in reporting poor sleep compared with actigraphic variables.
Post-traumatic stress disorder-specific sleep disturbances significantly affected the PTSD group as shown in the PSQI PTSD Addendum scores as well as the report of nightmares by 25% of the PTSD participants on the monitoring night. These sleep-disruptive behaviours did not appear to affect actigraphic sleep variables, but they may have biased diary reports of sleep. One month recall, often used in clinical and research settings, is likely to be inaccurate if there is much variability in the patient's sleep pattern over that month.
Another reason for last night's sleep being reported as better than past sleep could be that participants try not to exaggerate when accuracy can be checked by actigraph. Furthermore, actigraphic measures compared with PSG tend to underestimate the length of lying awake after sleep onset and might underestimate SOL, biasing these variables towards better sleep (Lichstein et al., 2006) . A possible factor affecting the monitored night's sleep is increased demand from wearing a device with instructions to press a To correct for sphericity. Greenhouse-Geisser F-values are reported; post hoc testing for repeated-measures with 1 month > 1 night, the Bonferroni-adjusted alpha levels are P > 0.001. *P < 0.05. **P < 0.01. ***P < 0.001. † Scores calculated without sleep medication questions or habitual sleep efficiency for comparison.
ª 2017 European Sleep Research Society button at certain times. A memory bias could cause a discrepancy between button presses and self-reported awakenings if pressing affects the memory of awakenings. Participants were instructed to write down each awakening in the diary in real-time, but we suspect that some completed the diary the next morning and incorrectly recalled their awakenings.
Our study had a number of limitations. We assessed actigraphic sleep for only 24 h, while other actigraphic studies used a period ranging from 2 to 14 nights (Ghadami et al., 2015; . Yet these studies were not any more successful than ours in finding discriminatory actigraphic measures. PSG has also failed to find worse sleep in PTSD . A weakness of actigraphy is that it is poor at detecting WASO in disturbed sleep, an important source of sleep complaints in PTSD. Actigraphy does not directly measure sleep apnea, which is prevalent in psychiatric populations (Sharafkhaneh et al., 2005) . Our decision to remove noncompliant participants from the analyses could have biased the results. Other research has identified missing marker button data as a significant problem in actigraphy monitoring (Ustinov and Lichstein, 2013) . Our 1-night version of the PSQI has not been tested or validated. Finally, our study did not collect nightly data during the previous month, which would have given information about variability in actigraphic data and self-reports (Kay et al., 2015; Lemola et al., 2013) . Our results highlight the need to supplement self-report with more objective measures when investigating sleep complaints. The addition of objective testing helps clinicians and researchers to better understand the nature of a person's sleep complaints and to choose the best interventions. Better wearable devices need to be developed that make overnight examination in a sleep laboratory less frequently necessary, as laboratory testing is expensive, non-ecological and makes multi-night assessment impractical. Night-to-night variability is often substantial among insomniacs and individuals with PTSD (Buysse et al., 2010; Straus et al., 2015) . Better assessment of PTSD-specific sleep disturbances, such as the NAW or amount of hyperarousal, should be combined with self-report to give clinicians a more complete picture of their patients' sleep. Improvement in self-report measures and their analysis is also possible. Two-or three-factor scoring for the PSQI may give a better fit than the current single-factor scoring for patients with PTSD (Babson et al., 2012; Casement et al., 2012; Mollayeva et al., 2016) . 
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